Publications of Sonja Horstmann
All genres
Journal Article (45)
1.
Journal Article
8 (6), e64947 (2013)
Possible Associations of NTRK2 Polymorphisms with Antidepressant Treatment Outcome: Findings from an Extended Tag SNP Approach. PLOS ONE 2.
Journal Article
44 (6), p. 295 - 295 (2011)
BDNF and NTRK2 polymorphisms and antidepressant treatment outcome. Pharmacopsychiatry 3.
Journal Article
69 (9 Suppl.1), p. 152 S - 152 S (2011)
BDNF and NTRK2 Polymorphisms and Antidepressant Treatment Response. Biological Psychiatry 4.
Journal Article
19 (3), pp. 125 - 143 (2011)
Glucocorticoids as Predictors of Treatment Response in Depression. Harvard Review of Psychiatry 5.
Journal Article
15 (7), pp. 736 - 747 (2010)
Variations in tryptophan hydroxylase 2 linked to decreased serotonergic activity are associated with elevated risk for metabolic syndrome in depression. Molecular Psychiatry 6.
Journal Article
67 (9 Suppl.1), pp. 127S - 128S (2010)
Polymorphisms in the BDNF Gene are Associated with Antidepressant Treatment Response. Biological Psychiatry 7.
Journal Article
67 (9 Suppl.1), p. 128S - 128S (2010)
Fine-Mapping of Genetic Loci Linked to REM-Density in the Munich Vulnerability Study. Biological Psychiatry 8.
Journal Article
42 (5), pp. 436 - 440 (2010)
Meta-analysis and imputation refines the association of 15q25 with smoking quantity. Nature Genetics 9.
Journal Article
67 (4), pp. 348 - 359 (2010)
Association of Genetic Variants in the Neurotrophic Receptor-Encoding Gene NTRK2 and a Lifetime History of Suicide Attempts in Depressed Patients. Archives of General Psychiatry 10.
Journal Article
20 (Suppl. 1), pp. S15 - S16 (2010)
Association of the adrenergic receptor alpha1B with antidepressant treatment in the MARS study. European Neuropsychopharmacology 11.
Journal Article
35 (3), pp. 727 - 740 (2010)
Polymorphisms in GRIK4, HTR2A, and FKBP5 Show Interactive Effects in Predicting Remission to Antidepressant Treatment. Neuropsychopharmacology 12.
Journal Article
20 (1), pp. 65 - 68 (2010)
HTR2A gene variation is involved in antidepressant treatment response. European Neuropsychopharmacology 13.
Journal Article
73, pp. 665 - 666 (2009)
Pharmacogenetics of antidepressant treatment outcome - Results from a genome-wide multilocus analysis including clinical predictors. Annals of Human Genetics 14.
Journal Article
124 (1), pp. 57 - 73 (2009)
Pharmacogenomics of antidepressant drugs. Pharmacology & Therapeutics 15.
Journal Article
42 (5), p. 222 - 222 (2009)
Clinical characteristics and treatment outcome in a representative sample of depressed inpatients - Findings from the Munich Antidepressant Response Signature project. Pharmacopsychiatry 16.
Journal Article
42 (5), p. 223 - 223 (2009)
Association of the adrenergic receptor alpha1B with antidepressant treatment in the MARS study. Pharmacopsychiatry 17.
Journal Article
66 (9), pp. 966 - 975 (2009)
A Genomewide Association Study Points to Multiple Loci That Predict Antidepressant Drug Treatment Outcome in Depression. Archives of General Psychiatry 18.
Journal Article
42 (5), p. 224 - 224 (2009)
A genome-wide association study points to multiple loci predicting antidepressant treatment outcome in depression. Pharmacopsychiatry 19.
Journal Article
42 (5), p. 226 - 226 (2009)
Polymorphisms in tryptophan hydroxylase 2 leading to decreased serotonergic activity contribute to elevated risk for metabolic syndrome in depression. Pharmacopsychiatry 20.
Journal Article
65 (8 Suppl. S), p. 230S - 230S (2009)
Association of the Adrenergic Receptor Alpha l B with Antidepressant Treatment in the MARS Study. Biological Psychiatry